CVS PHARMACY INC
Pharmacy · PLYMOUTH, MA
Organization Active NPI 1255431698
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,952 | 6,954 | $585,039 | $568,497 | $568,497 |
| 2023 | 1,883 | 8,087 | $411,975 | $381,325 | $381,325 |
| 2022 | 1,521 | 4,823 | $156,337 | $141,517 | $141,517 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 90480 | Admn sarscov2 vacc 1 dose | 1,666 | $43 | $43 |
| 91320 | Sarscv2 vac 30mcg trs-suc im | 1,652 | $149 | $149 |
| G0008 | Administration of influenza virus vaccine | 1,569 | $30 | $30 |
| 90662 | Influenza vaccine split virus, preservative free | 1,044 | $82 | $82 |
| 90653 | Influenza vaccine, inactivated | 457 | $82 | $82 |
| G0009 | Administration of pneumococcal vaccine | 242 | $32 | $32 |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 229 | $292 | $292 |
| 90661 | Influenza vaccine, trivalent derived from cell cultures | 36 | $36 | $36 |
| 90656 | Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 24 | $22 | $22 |
| 91304 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage, for intramuscular use | 14 | $156 | $156 |
| 90732 | Pneumococcal vaccine, 23-valent | 13 | $131 | $131 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Pharmacy | 333600000X | ✓ | 2073 | MA |
| Durable Medical Equipment & Medical Supplies | 332B00000X | — | — | |
| Community/Retail Pharmacy | 3336C0003X | — | — |
Other Pharmacy providers in Massachusetts
- NPI 1568561868
- NPI 1851490155
- NPI 1235644774
- NPI 1093720104
- NPI 1346766573
- NPI 1033722830
- NPI 1598618233
- NPI 1821043027
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.